PCM
FURX

Prelude Capital Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Prelude Capital Management’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,263
Closed -$418K – 2431
2014
Q1 		$371K Buy
+4,263
New +$329K 0.05% 518

Prelude Capital Management's FURX Position: Q2 2014 in Review

Prelude Capital Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q2 2014, closing a stake of 4,263 shares — an estimated $418K sold.

Prelude Capital Management first reported a position in FURX in Q1 2014 and held it in 1 quarter. The position peaked at $371K in Q1 2014. 102 funds tracked by Wall St. Rank hold FURX as of Q2 2014.

  • Prelude Capital Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Prelude Capital Management sold 4,263 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2014, an estimated $418K.
  • Prelude Capital Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 1 quarter.
  • Prelude Capital Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $371K in Q1 2014.
  • 102 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2014.

Based on Prelude Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.